Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

David A. Hyman, MD, JD, on Inclusive Shared Savings

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Opportunities to Optimize Cancer Policies Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Advertisement

Advertisement

Oct

01

Today In Oncology

Cleveland Clinic London Appoints Oncology Vice Chief

NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress

IARC Panel Provides International Determination on Lung Cancer Screening Benefits and Harms

Multicancer Early Detection Screening Does Not Reduce Overall Late-Stage Cancer Diagnosis

Can Long Distance Running Be a Risk Factor for Early-Onset Colorectal Cancer?

Advertisement

© 2026 HSP News Service, L.L.C.